Clinical Trials Logo

Clinical Trial Summary

Meconium constitutes the bowel contents of the fetus and is normally expelled only after birth. However, it may be secreted into the amniotic fluid of 20% of all fetuses. Meconium Stained Amniotic Fluid had been recognized from ancient times as an obstetric hazard which complicates delivery and is associated with increased newborn morbidity and mortality. At present there is no viable diagnostic test for Meconium prior to the onset of labor and the rupture of membranes. The system developed for the detection of Meconium, based on recognizing a characteristic fluoroscopic spectral pattern emitted by Meconium under light excitation at a specific wavelength. The diagnostic test being developed does not require penetration into the amniotic sac and is safe, painless and simple to perform.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01429974
Study type Observational
Source Sheba Medical Center
Contact
Status Terminated
Phase N/A
Start date September 2011
Completion date July 7, 2015

See also
  Status Clinical Trial Phase
Completed NCT03969459 - Impact of Exposure to Persistent Organic Pollutants During Pregnancy on the Composition of Breast Milk and Consequences on the Newborn